KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to -$6.6 million.

  • Fulgent Genetics' Net Income towards Common Stockholders rose 5488.8% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.0 million, marking a year-over-year increase of 7394.48%. This contributed to the annual value of -$42.7 million for FY2024, which is 7455.21% up from last year.
  • As of Q3 2025, Fulgent Genetics' Net Income towards Common Stockholders stood at -$6.6 million, which was up 5488.8% from -$19.0 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Net Income towards Common Stockholders peaked at $200.7 million during Q1 2021, and registered a low of -$128.1 million during Q4 2023.
  • Its 5-year average for Net Income towards Common Stockholders is $20.9 million, with a median of -$8.7 million in 2024.
  • As far as peak fluctuations go, Fulgent Genetics' Net Income towards Common Stockholders skyrocketed by 1185694.2% in 2021, and later plummeted by 107594.94% in 2023.
  • Quarter analysis of 5 years shows Fulgent Genetics' Net Income towards Common Stockholders stood at $103.7 million in 2021, then tumbled by 123.22% to -$24.1 million in 2022, then crashed by 432.27% to -$128.1 million in 2023, then soared by 95.41% to -$5.9 million in 2024, then decreased by 12.23% to -$6.6 million in 2025.
  • Its Net Income towards Common Stockholders was -$6.6 million in Q3 2025, compared to -$19.0 million in Q2 2025 and -$11.5 million in Q1 2025.